Literature DB >> 25705465

Crystal structure of (S)-4-carbamoyl-4-(1,3-dioxo-isoindolin-2-yl)butanoic acid.

Kohei Otogawa1, Kazuhiko Ishikawa1, Motoo Shiro2, Toru Asahi3.   

Abstract

In the title compound, C13H12N2O5, the phthalimide ring system is essentially planar, with a maximum deviation of 0.0479 (14) Å. In the crystal, each mol-ecule is linked via six neighbouring mol-ecules into a three-dimensional network through N-H⋯O and O-H⋯O hydrogen bonds, which form an R 3 (2)(8) ring motif.

Entities:  

Keywords:  crystal structure; hydrogen bonds; thalidomide

Year:  2015        PMID: 25705465      PMCID: PMC4331919          DOI: 10.1107/S2056989014027121

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The title compound, 5-(amin­oxy)-4-(3-oxo-2H-isoindol-2-oyl)valeric acid (phthaloylisoglutamine), is one of the first-step hydrolysis products of thalidomide. Thalidomide was first synthesized in 1953 and was marketed as a hypnotic medicine in 1956. After that, the teratogenic side effect of thalidomide was proved and caused serious drug disaster (Lenz, 1961 ▸). Blashke et al. (1979 ▸) reported that only (S)-thalidomide exhibits teratogenicity while (R)-thalidomide exhibits sedative effects. In other words, the hypnotic and teratogenic mechanisms of thalidomide are different. For a long time, the target protein of thalidomide has not been clarified. However in 2010, the protein cereblon, which is one of the E3 ubiquitin ligase proteins, was identified as the primary target of thalidomide teratogenicity (Ito et al., 2010 ▸). Furthermore, the conformation of a Cereblon and thalidomide complex has been reported (Fischer et al., 2014 ▸). Hydrolysis compounds of thalidomide are generated rapidly in vivo (Schumacher et al., 1965 ▸; Nishimura et al., 1994 ▸) and some of these showed TNF-α production-inhibitory activity (Nakamura et al., 2007 ▸). Although the crystal structures of racemic and enanti­omeric thalidomide were solved and reported earlier (Allen & Trotter, 1971 ▸; Suzuki et al., 2010 ▸), the crystal structures of hydrolysis compounds of thalidomide have not been reported. Considering that knowing the structure of the mol­ecule enables us to calculate the affinity between ligand and receptor using computer simulation, our report herein will be helpful in clarifying the differences between the biological effects of thalidomide and phthaloylisoglutamine.

Structural commentary

The mol­ecular structure of the title mol­ecule is shown in Fig. 1 ▸. The asymmetric center is S for atom C9. The phthalimide ring (N1/C1–C8) is essentially planar, with a maximum deviation of 0.0479 (14) Å for N1. The carbonoxygen distances in the carb­oxy group (COOH) show different lengths [C13—O4 = 1.206 (2) and C13—O5 = 1.316 (2) Å]. This difference indicates that the C—O bonds in the carb­oxy group are non-delocalized. These bonds are slightly strengthened by inter­molecular O5—H12⋯O3 and O4⋯H7A—N2 hydrogen bonding (Fig. 2 ▸). The conformation of C9—C11—C12—C13 chain is slightly twisted gauche [torsion angle = 77.4 (2)°].
Figure 1

The mol­ecular structure of the title compound, showing displacement ellipsoids at the 50% probability level.

Figure 2

A trimer structure of the title compound and an (8) ring motif formed through O5iii—H12iii⋯O3ii, N2—H6B⋯O3ii and N2—H7A⋯O4iii hydrogen bonds. [Symmetry codes: (ii) x + , −y + , −z + 1; (iii) −x + 1, y − , −z + .]

Supra­molecular features

In the crystal structure, each mol­ecule has six hydrogen bonds, which are divided into three types (Table 1 ▸). The three hydrogen bonds form a hydrogen-bonded ring with an (8) ring motif, which unites three mol­ecules (Fig. 2 ▸). Taken together as shown in Fig. 3 ▸, one mol­ecule (yellow) is linked to another six mol­ecules (blue, red, and green) by three sets of circular hydrogen bonds.
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
O5H12O3i 0.831.802.6230(19)172
N2H6BO3ii 0.872.322.891(2)123
N2H7AO4iii 0.872.052.886(2)161

Symmetry codes: (i) ; (ii) ; (iii) .

Figure 3

A crystal packing view of the title compound, showing the inter­molecular hydrogen bonds. A yellow mol­ecule is linked with two red, two green and two blue mol­ecules.

Database survey

A search of the Cambridge Structural Database (Version 5.35 update in 2014; Groom & Allen, 2014 ▸) for the structure of thalidomide gave 11 hits, but there was no hydrolysis compound of thalidomide.

Synthesis and crystallization

The title compound was purchased from WuXi AppTec. The title compound (2 mg) was dissolved in ethanol (500 µl). After a few days of slow evaporation at 278 K, colourless single crystals suitable for X-ray diffraction were obtained.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. All H atoms were included in calculated positions [C—H (aromatic) = 0.93, C—H (methine) = 0.98, C—H (methyl­ene) = 0.97, N—H = 0.87 and O—H = 0.82 Å] and treated as riding atoms with U iso(H) = 1.2U eq(C) and 1.5U eq(N, O).
Table 2

Experimental details

Crystal data
Chemical formulaC13H12N2O5
M r 276.25
Crystal system, space groupOrthorhombic, P212121
Temperature (K)223
a, b, c ()8.4790(3), 9.6751(3), 15.4488(5)
V (3)1267.35(7)
Z 4
Radiation typeCu K
(mm1)0.96
Crystal size (mm)0.63 0.20 0.10
 
Data collection
DiffractometerRigaku R-AXIS RAPID
Absorption correctionMulti-scan (ABSCOR; Rigaku, 1995)
T min, T max 0.766, 0.908
No. of measured, independent and observed [F 2 > 2(F 2)] reflections23228, 2320, 2245
R int 0.058
(sin /)max (1)0.602
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.027, 0.067, 1.08
No. of reflections2320
No. of parameters183
H-atom treatmentH-atom parameters constrained
max, min (e 3)0.16, 0.16
Absolute structureFlack x determined using 914 quotients [(I +)(I )]/[(I +)+(I )] (Parsons et al., 2013)
Absolute structure parameter0.06(4)

Computer programs: RAPID-AUTO (Rigaku, 1998 ▸), SHELXS2013 and SHELXL2013 (Sheldrick, 2008 ▸) and CrystalStructure (Rigaku, 2014 ▸).

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S2056989014027121/is5381sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989014027121/is5381Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014027121/is5381Isup3.cml CCDC reference: 1038803 Additional supporting information: crystallographic information; 3D view; checkCIF report
C13H12N2O5Dx = 1.448 Mg m3
Mr = 276.25Cu Kα radiation, λ = 1.54187 Å
Orthorhombic, P212121Cell parameters from 12101 reflections
a = 8.4790 (3) Åθ = 4.6–68.3°
b = 9.6751 (3) ŵ = 0.96 mm1
c = 15.4488 (5) ÅT = 223 K
V = 1267.35 (7) Å3Needle, colorless
Z = 40.63 × 0.20 × 0.10 mm
F(000) = 576.00
Rigaku R-AXIS RAPID diffractometer2245 reflections with F2 > 2σ(F2)
Detector resolution: 10.000 pixels mm-1Rint = 0.058
ω scansθmax = 68.2°, θmin = 5.4°
Absorption correction: multi-scan (ABSCOR; Rigaku, 1995)h = −10→10
Tmin = 0.766, Tmax = 0.908k = −11→11
23228 measured reflectionsl = −18→18
2320 independent reflections
Refinement on F2H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.027w = 1/[σ2(Fo2) + (0.0326P)2 + 0.1235P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.067(Δ/σ)max < 0.001
S = 1.08Δρmax = 0.16 e Å3
2320 reflectionsΔρmin = −0.16 e Å3
183 parametersExtinction correction: SHELXL2013 (Sheldrick, 2008)
0 restraintsExtinction coefficient: 0.0357 (16)
Primary atom site location: structure-invariant direct methodsAbsolute structure: Flack x determined using 914 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Secondary atom site location: difference Fourier mapAbsolute structure parameter: 0.06 (4)
Hydrogen site location: inferred from neighbouring sites
Refinement. Refinement was performed using all reflections. The weighted R-factor (wR) and goodness of fit (S) are based on F2. R-factor (gt) are based on F. The threshold expression of F2 > 2.0 σ(F2) is used only for calculating R-factor (gt).
xyzUiso*/Ueq
O10.60120 (16)0.50832 (14)0.65955 (9)0.0380 (4)
O20.22423 (15)0.29086 (15)0.81979 (8)0.0354 (3)
O30.28367 (17)0.34228 (17)0.49573 (8)0.0435 (4)
O40.32128 (15)0.66161 (14)0.78685 (8)0.0353 (3)
O50.08071 (16)0.6519 (2)0.84322 (9)0.0498 (4)
N10.39627 (16)0.38300 (15)0.71946 (9)0.0246 (3)
N20.48080 (19)0.24502 (17)0.57047 (10)0.0342 (4)
C10.7414 (2)0.4824 (2)0.84759 (13)0.0358 (4)
C20.7647 (2)0.4539 (2)0.93501 (13)0.0416 (5)
C30.6535 (2)0.3840 (2)0.98308 (13)0.0395 (5)
C40.5124 (2)0.3393 (2)0.94584 (11)0.0326 (4)
C50.4892 (2)0.36838 (17)0.85916 (11)0.0255 (4)
C60.6010 (2)0.43761 (18)0.81107 (11)0.0274 (4)
C70.5420 (2)0.45217 (18)0.72098 (11)0.0266 (4)
C80.3518 (2)0.33864 (17)0.80233 (11)0.0250 (4)
C90.2867 (2)0.38767 (19)0.64668 (11)0.0269 (4)
C100.3548 (2)0.32287 (19)0.56467 (11)0.0281 (4)
C110.2218 (2)0.5328 (2)0.62906 (12)0.0337 (4)
C120.1075 (2)0.5854 (2)0.69751 (13)0.0396 (5)
C130.1827 (2)0.63585 (19)0.77980 (12)0.0311 (4)
H10.817480.529940.81480.0429*
H20.858470.482960.961850.0499*
H30.672960.366051.041920.0475*
H40.436280.29150.978380.0392*
H50.195120.329990.663360.0323*
H6B0.517940.204270.524590.0513*
H7A0.527310.234070.620190.0513*
H8A0.310490.597370.624940.0404*
H9B0.168010.532330.57290.0404*
H10A0.045760.661220.672530.0475*
H11B0.033870.510820.711930.0475*
H120.12880.660530.88970.0747*
U11U22U33U12U13U23
O10.0368 (7)0.0480 (8)0.0294 (7)−0.0115 (7)0.0044 (6)0.0064 (6)
O20.0285 (7)0.0478 (8)0.0299 (7)−0.0078 (6)0.0024 (6)0.0079 (6)
O30.0411 (8)0.0673 (10)0.0221 (7)0.0098 (8)−0.0079 (6)−0.0063 (6)
O40.0307 (7)0.0439 (7)0.0313 (7)−0.0037 (6)−0.0003 (6)−0.0053 (6)
O50.0331 (7)0.0856 (12)0.0306 (8)−0.0014 (8)0.0020 (6)−0.0085 (8)
N10.0237 (7)0.0314 (7)0.0188 (7)−0.0022 (6)−0.0007 (6)0.0021 (6)
N20.0352 (9)0.0442 (9)0.0233 (8)0.0063 (7)−0.0016 (7)−0.0053 (7)
C10.0269 (9)0.0432 (10)0.0373 (11)−0.0013 (9)−0.0037 (8)−0.0049 (9)
C20.0322 (10)0.0538 (12)0.0388 (11)0.0062 (10)−0.0146 (9)−0.0102 (10)
C30.0436 (12)0.0508 (11)0.0243 (10)0.0134 (10)−0.0094 (9)−0.0036 (9)
C40.0362 (10)0.0392 (10)0.0225 (9)0.0074 (9)0.0008 (8)0.0014 (8)
C50.0262 (9)0.0286 (9)0.0219 (9)0.0046 (7)0.0000 (7)−0.0023 (7)
C60.0257 (8)0.0315 (8)0.0251 (9)0.0030 (8)−0.0013 (7)−0.0024 (8)
C70.0239 (8)0.0315 (8)0.0244 (9)−0.0024 (7)0.0012 (7)0.0001 (8)
C80.0272 (9)0.0268 (8)0.0210 (8)0.0026 (7)0.0004 (7)0.0023 (7)
C90.0242 (8)0.0364 (9)0.0203 (9)−0.0034 (7)−0.0031 (7)0.0016 (8)
C100.0259 (9)0.0366 (9)0.0217 (9)−0.0053 (8)−0.0027 (7)0.0003 (7)
C110.0376 (10)0.0409 (10)0.0226 (9)0.0074 (9)−0.0064 (8)0.0017 (8)
C120.0318 (9)0.0517 (12)0.0351 (11)0.0115 (9)−0.0089 (9)−0.0073 (9)
C130.0321 (10)0.0321 (9)0.0291 (10)0.0051 (8)−0.0018 (8)0.0016 (8)
O1—C71.203 (2)C9—C101.527 (2)
O2—C81.207 (2)C9—C111.532 (3)
O3—C101.238 (2)C11—C121.522 (3)
O4—C131.206 (2)C12—C131.503 (3)
O5—C131.316 (2)O5—H120.830
N1—C71.405 (2)N2—H6B0.870
N1—C81.402 (2)N2—H7A0.870
N1—C91.460 (2)C1—H10.940
N2—C101.310 (2)C2—H20.940
C1—C21.393 (3)C3—H30.940
C1—C61.387 (3)C4—H40.940
C2—C31.378 (3)C9—H50.990
C3—C41.396 (3)C11—H8A0.980
C4—C51.382 (2)C11—H9B0.980
C5—C61.378 (2)C12—H10A0.980
C5—C81.487 (2)C12—H11B0.980
C6—C71.486 (2)
C7—N1—C8111.52 (14)O4—C13—C12123.81 (17)
C7—N1—C9123.92 (14)O5—C13—C12112.90 (16)
C8—N1—C9122.81 (14)C13—O5—H12109.469
C2—C1—C6117.00 (17)C10—N2—H6B120.005
C1—C2—C3121.55 (19)C10—N2—H7A120.001
C2—C3—C4121.08 (18)H6B—N2—H7A119.994
C3—C4—C5117.28 (17)C2—C1—H1121.519
C4—C5—C6121.54 (16)C6—C1—H1121.506
C4—C5—C8130.11 (16)C1—C2—H2119.202
C6—C5—C8108.34 (15)C3—C2—H2119.210
C1—C6—C5121.54 (16)C2—C3—H3119.482
C1—C6—C7129.83 (16)C4—C3—H3119.476
C5—C6—C7108.63 (15)C3—C4—H4121.355
O1—C7—N1124.67 (16)C5—C4—H4121.352
O1—C7—C6129.86 (16)N1—C9—H5106.340
N1—C7—C6105.47 (14)C10—C9—H5106.336
O2—C8—N1124.22 (16)C11—C9—H5106.343
O2—C8—C5130.12 (16)C9—C11—H8A108.681
N1—C8—C5105.63 (14)C9—C11—H9B108.685
N1—C9—C10112.66 (14)C12—C11—H8A108.682
N1—C9—C11113.19 (15)C12—C11—H9B108.682
C10—C9—C11111.39 (14)H8A—C11—H9B107.616
O3—C10—N2122.91 (17)C11—C12—H10A108.474
O3—C10—C9117.83 (16)C11—C12—H11B108.468
N2—C10—C9119.20 (15)C13—C12—H10A108.470
C9—C11—C12114.32 (16)C13—C12—H11B108.470
C11—C12—C13115.22 (16)H10A—C12—H11B107.495
O4—C13—O5123.27 (17)
C7—N1—C8—O2171.27 (15)C4—C5—C6—C7179.74 (15)
C7—N1—C8—C5−6.74 (17)C4—C5—C8—O25.8 (3)
C8—N1—C7—O1−174.78 (15)C4—C5—C8—N1−176.37 (17)
C8—N1—C7—C65.92 (17)C6—C5—C8—O2−172.97 (16)
C7—N1—C9—C1063.76 (19)C6—C5—C8—N14.88 (17)
C7—N1—C9—C11−63.74 (19)C8—C5—C6—C1178.32 (13)
C9—N1—C7—O1−9.5 (3)C8—C5—C6—C7−1.38 (18)
C9—N1—C7—C6171.19 (13)C1—C6—C7—O1−1.5 (3)
C8—N1—C9—C10−132.59 (14)C1—C6—C7—N1177.71 (17)
C8—N1—C9—C1199.91 (17)C5—C6—C7—O1178.13 (16)
C9—N1—C8—O25.8 (2)C5—C6—C7—N1−2.62 (18)
C9—N1—C8—C5−172.20 (13)N1—C9—C10—O3−167.77 (14)
C2—C1—C6—C50.2 (3)N1—C9—C10—N215.1 (2)
C2—C1—C6—C7179.85 (16)N1—C9—C11—C12−70.37 (18)
C6—C1—C2—C30.2 (3)C10—C9—C11—C12161.47 (13)
C1—C2—C3—C4−0.2 (3)C11—C9—C10—O3−39.3 (2)
C2—C3—C4—C5−0.1 (3)C11—C9—C10—N2143.54 (15)
C3—C4—C5—C60.5 (3)C9—C11—C12—C1377.4 (2)
C3—C4—C5—C8−178.13 (16)C11—C12—C13—O415.2 (3)
C4—C5—C6—C1−0.6 (3)C11—C12—C13—O5−166.20 (15)
D—H···AD—HH···AD···AD—H···A
O5—H12···O3i0.831.802.6230 (19)172
N2—H6B···O3ii0.872.322.891 (2)123
N2—H7A···O4iii0.872.052.886 (2)161
  9 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  The Cambridge Structural Database in retrospect and prospect.

Authors:  Colin R Groom; Frank H Allen
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-02       Impact factor: 15.336

3.  [Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's transl)].

Authors:  G Blaschke; H P Kraft; K Fickentscher; F Köhler
Journal:  Arzneimittelforschung       Date:  1979

4.  The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species.

Authors:  H Schumacher; R L Smith; R T Williams
Journal:  Br J Pharmacol Chemother       Date:  1965-10

5.  Hydrolyzed metabolites of thalidomide: synthesis and TNF-alpha production-inhibitory activity.

Authors:  Takanori Nakamura; Tomomi Noguchi; Hiroyuki Miyachi; Yuichi Hashimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-04       Impact factor: 1.645

6.  Identification of a primary target of thalidomide teratogenicity.

Authors:  Takumi Ito; Hideki Ando; Takayuki Suzuki; Toshihiko Ogura; Kentaro Hotta; Yoshimasa Imamura; Yuki Yamaguchi; Hiroshi Handa
Journal:  Science       Date:  2010-03-12       Impact factor: 47.728

7.  (S)-form of alpha-methyl-N(alpha)-phthalimidoglutarimide, but not its (R)-form, enhanced phorbol ester-induced tumor necrosis factor-alpha production by human leukemia cell HL-60: implication of optical resolution of thalidomidal effects.

Authors:  K Nishimura; Y Hashimoto; S Iwasaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-05       Impact factor: 1.645

8.  Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.

Authors:  Eric S Fischer; Kerstin Böhm; John R Lydeard; Haidi Yang; Michael B Stadler; Simone Cavadini; Jane Nagel; Fabrizio Serluca; Vincent Acker; Gondichatnahalli M Lingaraju; Ritesh B Tichkule; Michael Schebesta; William C Forrester; Markus Schirle; Ulrich Hassiepen; Johannes Ottl; Marc Hild; Rohan E J Beckwith; J Wade Harper; Jeremy L Jenkins; Nicolas H Thomä
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962

9.  Use of intensity quotients and differences in absolute structure refinement.

Authors:  Simon Parsons; Howard D Flack; Trixie Wagner
Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater       Date:  2013-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.